Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of 24-hour intraocular pressure reduction obtained with brinzolamide/timolol or brimonidine/timolol fixed-combination adjunctive to travoprost therapy.
Konstas AG, Holló G, Haidich AB, Mikropoulos DG, Giannopoulos T, Voudouragkaki IC, Paschalinou E, Konidaris V, Samples JR. Konstas AG, et al. Among authors: haidich ab. J Ocul Pharmacol Ther. 2013 Sep;29(7):652-7. doi: 10.1089/jop.2012.0195. Epub 2013 Apr 3. J Ocul Pharmacol Ther. 2013. PMID: 23550916 Clinical Trial.
Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma.
Konstas AG, Holló G, Mikropoulos D, Tsironi S, Haidich AB, Embeslidis T, Georgiadou I, Irkec M, Melamed S. Konstas AG, et al. Among authors: haidich ab. Br J Ophthalmol. 2010 Feb;94(2):209-13. doi: 10.1136/bjo.2008.155317. Epub 2009 Oct 12. Br J Ophthalmol. 2010. PMID: 19825835 Clinical Trial.
Prostaglandin-timolol fixed combinations efficacy: myth or reality?
Konstas AG, Haidich AB, Rossetti L, Webers C. Konstas AG, et al. Among authors: haidich ab. Eur J Ophthalmol. 2012 Jan-Feb;22(1):1-4. doi: 10.5301/ejo.5000077. Eur J Ophthalmol. 2012. PMID: 22167537 Free article. No abstract available.
Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension.
Konstas AG, Quaranta L, Katsanos A, Riva I, Tsai JC, Giannopoulos T, Voudouragkaki IC, Paschalinou E, Floriani I, Haidich AB. Konstas AG, et al. Among authors: haidich ab. Br J Ophthalmol. 2013 Dec;97(12):1510-5. doi: 10.1136/bjophthalmol-2012-303026. Epub 2013 May 16. Br J Ophthalmol. 2013. PMID: 23681371 Clinical Trial.
24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma.
Konstas AG, Holló G, Mikropoulos DG, Haidich AB, Dimopoulos AT, Empeslidis T, Teus MA, Ritch R. Konstas AG, et al. Among authors: haidich ab. Br J Ophthalmol. 2013 Jul;97(7):857-61. doi: 10.1136/bjophthalmol-2012-302843. Epub 2013 May 18. Br J Ophthalmol. 2013. PMID: 23686322 Clinical Trial.
24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy.
Konstas AG, Boboridis KG, Kapis P, Marinopoulos K, Voudouragkaki IC, Panayiotou D, Mikropoulos DG, Pagkalidou E, Haidich AB, Katsanos A, Quaranta L. Konstas AG, et al. Among authors: haidich ab. Adv Ther. 2017 Jan;34(1):221-235. doi: 10.1007/s12325-016-0448-9. Epub 2016 Dec 2. Adv Ther. 2017. PMID: 27913991 Free PMC article. Clinical Trial.
208 results